Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 15Myelodysplastic Syndromes 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Leukemia, Myelomonocytic, Chronic 8Hematologic Neoplasms 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia, Biphenotypic, Acute 7Hodgkin Disease 6Lymphoma, Non-Hodgkin 5Graft vs Host Disease 5Anemia, Refractory, with Excess of Blasts 4Primary Myelofibrosis 3Myeloproliferative Disorders 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Multiple Myeloma 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Prolymphocytic 2Leukemia 2Burkitt Lymphoma 2Bronchiolitis Obliterans Syndrome 2beta-Thalassemia 1Thrombocythemia, Essential 1Thalassemia 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Non-Malignant Neoplasm 1Myasthenia Gravis 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Standard of Care 3Practice Guidelines as Topic 3Interviews as Topic 2fludarabine 1Whole-Body Irradiation 1Watchful Waiting 1Telemedicine 1Tacrolimus 1Stem Cell Transplantation 1Rituximab 1Palliative Care 1Observation 1Mycophenolic Acid 1Methods 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Geriatric Assessment 1Filgrastim 1Educational Status 1Early Intervention, Educational 1Cyclophosphamide 1Counseling 1CT-P10 1Bendamustine Hydrochloride 1Behavior Therapy 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hematopoietic and Lymphoid System Neoplasm × Mycophenolic Acid × Clear all
NCT04022239 2026-01-12

Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant

M.D. Anderson Cancer Center

Phase 1/2 Recruiting
25 enrolled

Hematopoietic and Lymphoid System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡